Authors
Latest:
Debate Continues to Swirl Around Right to Try LawsForms of right to try legislation have already been passed in 39 states, as well as in the House of Representatives and Senate.
Latest:
Bilateral Psoas Abscess Treated with Multiple Antibiotic RegimensAbscesses can occur in obscure places in the body, including the psoas muscle.
Latest:
Overcoming Challenges of Insulin Therapy in Type 2 Diabetes: Exploring Emerging OptionsThis Continuing Education activity is supported by an educational grant from Sanofi-Aventis U.S.
Latest:
Provision of Diabetes Sick-Day Plans in the Community PharmacyAs community pharmacists, we are often the most accessible members of the health care team.
Latest:
Specialty Pharmaceuticals: Therapy Class Review: Macular DegenerationWith the novel agents in the age-related macular degeneration pipeline, drug makers are taking advantage of an opportunity for innovation.
Latest:
Analyzing the Impact of Different Value-Based Insurance Design ProgramsTotal 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.
Latest:
Working Together to Distinguish Hospital, Health System Specialty Pharmacy ServicesHow health system specialty pharmacies can leverage data to differentiate the impact of the high-touch, integrated care model and create value for all pharmacy stakeholders.
Latest:
Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine DevicesThis analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.
Latest:
Sun Protection: Pharmacists Have the FactsChoosing the right sun protection option can be more complicated than it was in the past.
Latest:
Drug Review: Daklinza for Chronic Hepatitis C InfectionAn overview of Daklinza (daclatasvir) for pharmacists.
Latest:
Oral Semaglutide for the Management of Type 2 Diabetes MellitusSome pertinent information pharmacists should know about oral semaglutide
Latest:
THE PHARMACEUTICAL INDUSTRY: CONTRIBUTING TO BETTER MEDICINESDrs. Patel, Singh, and Whalen are postdoctoral fellows in the Rutgers Pharmaceutical Industry Fellowship Program. Dr. Alexander is director of the Institute for Pharmaceutical Industry Fellowships, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey. Dr. Barone is professor and chair of the Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey.
Latest:
GoutGout is a chronic, inflammatory form of arthritis that is increasing in prevalence in the United States. There are a variety of pharmacologic and nonpharmacologic options for treating and preventing flares of gout.
Latest:
Survey Asks Pharmacists About Potential Pet PoisonsA recent survey evaluated the baseline knowledge of licensed pharmacists with regard to common pet toxins.
Latest:
The Road Less Traveled: Nontraditional Work Arrangements in AcademiaAccording to the 2014 National Pharmacist Workforce Study, approximately 18.7% of women and 16.4% of men actively engaged as pharmacists reported working part-time.
Latest:
Medicare Part D Insulin Tiering Change: Impact on Health OutcomesThis study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Latest:
To Substitute or Not to Substitute: That Is the QuestionWith generic prescriptions on the rise, every pharmacist needs a through understanding of therapeutic equivalence and the generic approval process.
Latest:
Developing Optimal Patient Medication InformationPatient medication information should be the most critical information in a patient-friendly format so that individuals can make the most informed decisions about their drugs.
Latest:
Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast CancerCompared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.
Latest:
Pharmacists in ACOs Part 3: Chronic Care Management, Chronic Disease State Management, and Transition of CareAfter discussing the Basics of Accountable Care Organizations and Medication Therapy Management and Annual Wellness Visit services, the third and last section of the Pharmacists in ACOs series will focus on 3 more integration strategies for pharmacists within the ACO setting, including chronic care management, chronic disease state management, and transitions of care.
Latest:
Impact of Medicaid Preferred Drug List on Long-Acting Opioid UsersAn opioid preferred drug list was not associated with an increase in emergency department visits or hospitalizations in a Medicaid population.
Latest:
How Do Pharmacies Evaluate Cleanroom Automation Systems?Check out these pre- and postimplementation checklists, which also help to justify the investment.
